Eppley B L, Doucet M, Connolly D T, Feder J
Division of Oral-Maxillofacial Surgery, St. John's Mercy Medical Center, St. Louis, MO 63141.
J Oral Maxillofac Surg. 1988 May;46(5):391-8. doi: 10.1016/0278-2391(88)90223-6.
The effectiveness of basic fibroblast growth factor (bFGF) as an in vivo angiogenic factor was evaluated in autogeneic bone grafts to the rabbit mandible. Block cortical grafts harvested from the ilium were implanted into sites in the mandibular ramus or body. The basic fibroblast growth factor was continuously introduced over a period of 14 days through subcutaneous osmotic pumps. Increased vascularity, as assessed by vessel number and depth of penetration into the grafts, was noted at 10 days postoperatively in the bFGF stimulated side as compared to contralateral control grafts. At the fourteenth postoperative day, bFGF administration was discontinued and a decrease in angiogenesis was noted over the ensuing 2 weeks so that after 1 postoperative month, little difference could be detected between the stimulated and nonstimulated grafts. Assessment of osseous healing at the 1 month postoperative interval using triple fluorochrome labeling did not reveal evidence of accelerated osteogenesis on the previously stimulated side.
在兔下颌骨的自体骨移植中,评估了碱性成纤维细胞生长因子(bFGF)作为体内血管生成因子的有效性。从髂骨采集的块状皮质骨移植到下颌支或下颌体的部位。碱性成纤维细胞生长因子通过皮下渗透泵在14天的时间内持续输注。与对侧对照移植相比,在术后10天,通过血管数量和血管向移植物内的渗透深度评估,发现bFGF刺激侧的血管增多。术后第14天,停止给予bFGF,在随后的2周内观察到血管生成减少,因此术后1个月时,刺激侧和未刺激侧的移植物之间几乎没有差异。在术后1个月时使用三重荧光染料标记评估骨愈合情况,未发现先前刺激侧有加速成骨的证据。